Insulin Glargine 100 IU/mLInjection
Diabetes & Metabolic

Insulin Glargine 100 IU/mL

Insulin Glargine

Recombinant long-acting basal insulin analog engineered for a peakless, 24-hour action profile through subcutaneous microprecipitate formation, enabling consistent once-daily dosing without the pronounced peak-related hypoglycemia seen with NPH insulin. Sanofi Lantus biosimilars from Biocon and other Indian manufacturers have significantly expanded access in emerging markets.

Strengths

100 IU/mL

Packing

1 pen/box (3ml)

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Insulin Glargine 100 IU/mL (recombinant human insulin analog)
Dosage Form
Injection
Available Strengths
100 IU/mL
Packing
1 pen/box (3ml)
Route of Administration
Subcutaneous injection at same time each day
Dosage
Individualized based on metabolic needs; T2DM starting dose: 0.2 units/kg or 10 units once daily; titrate based on fasting glucose targets
Indications
Type 1 diabetes mellitus, type 2 diabetes mellitus requiring basal insulin, gestational diabetes (under specialist supervision)
Country of Origin
India (WHO-GMP Certified)
Storage
Unopened: refrigerate 2-8°C; In-use: store at room temperature below 30°C for up to 28 days; do not freeze
Shelf Life
24 months (unopened)
Side Effects
Hypoglycemia, injection site reactions (lipodystrophy, redness, swelling), weight gain, hypokalemia, allergic reactions
Precautions
Do not mix with other insulins; rotate injection sites; hypoglycemia management education mandatory; monitor potassium; adjust dose during illness, exercise changes, or dietary changes

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Glimepiride 2mgTablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg
Sitagliptin 100mgTablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg
Vildagliptin 50mgTablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg

Need bulk pricing for Insulin Glargine 100 IU/mL?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote